Senior Global Access Evidence Leader - HTA Statistician

Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage l'expression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour ce que vous êtes, vous permettant de prospérer tant personnellement que professionnellement. Voici comment nous visons à prévenir, arrêter et guérir les maladies et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir.

Rejoignez Roche, où chaque voix compte.

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference.

Within GPS, the Global Access (GA) department is dedicated to delivering sustainable, replicable, and scalable global strategies, policies, and solutions. Our mission is to support the Pharma Vision, enabling affiliates to drive patient access locally while improving value for society, healthcare ecosystems, and Roche’s business. We operate in a highly networked and agile model with stable chapters and flexible squads and work teams across the product lifecycle, disease areas, functions, and geographies, with chapters built around the expertise and capabilities needed to co-create and deliver integrated solutions.

Role Overview

We are seeking a dynamic and visionary Senior Global Access Evidence Leader with deep EU HTA and advanced statistical and evidence-synthesis expertise to join our Evidence Chapter—a professional recognized within the European HTA community for advancing evidence standards and shaping submissions that secure patient access across EU member states. In this role, you will thrive in a collaborative environment and be passionate about making a difference.

• Lead EU HTA evidence strategy:
  Shape Roche's approach to EU HTA submissions by embedding sophisticated, anticipatory evidence strategies into clinical development from inception, ensuring alignment with EMA regulations, and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets.
• Drive methodological innovation in EU contexts:
  Leverage your established networks within European HTA bodies, payers, and health authorities to advance evidence standards and best practices—influencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks.
• Architect compelling EU submissions:
  Design innovative, region-specific evidence packages that anticipate the needs of EMA committees, HTA bodies and national payers. Identify strategic evidence gaps early, pioneer novel data sources and analyses, and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets.
• Establish Roche as an EU HTA expert:
  Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality, engage proactively with key opinion leaders and HTA bodies, and position Roche as a thought leader in EU evidence generation and submission strategy.
• Lead strategic statistical analysis for EU evidence packages:
  Lead and critically evaluate complex statistical analyses—including network meta-analyses and real-world evidence syntheses—ensuring methodological rigor and compliance with EU HTA requirements…